Abstract | Intrinsically disordered proteins (IDPs) are important components of the cellular signalling machinery, allowing the same polypeptide to undertake different interactions with different consequences. IDPs are subject to combinatorial post-translational modifications and alternative splicing, adding complexity to regulatory networks and providing a mechanism for tissue-specific signalling. These proteins participate in the assembly of signalling complexes and in the dynamic self-assembly of membrane-less nuclear and cytoplasmic organelles. Experimental, computational and bioinformatic analyses combine to identify and characterize disordered regions of proteins, leading to a greater appreciation of their widespread roles in biological processes.
The abundance and functional significance of protein disorder in eukaryotes was largely unrecognized before the mid-1990s. Around that time, experimental studies on regulatory proteins and parallel bioinformatics interrogation of the complete genome sequences that were just beginning to emerge revealed that regions of disorder are very common in eukaryotic proteins, especially those involved in cellular regulation and signallin g (reviewed in REFS 1, 2) . Intrinsically disordered proteins (IDPs; also known as intrinsically unstructured proteins) are characterized by their biased amino acid composition and low sequence complexity, as well as by their low proportions of bulky hydro phobic amino acids and high proportions of charged and hydrophilic amino acids. Despite being perfectly functional, such protein sequences are unable to fold spontaneously into stable, well-defined, globular three-dimensional structures; instead, they are dynamically disordered and fluctuate rapidly through a range of conformations, which cover a continuum of conformational space ranging from extended statistical coils to collapsed globules 3 . Some proteins are predicted to be entirely disordered, whereas others contain disordered sequences, referred to as intrinsically disordered regions (IDRs), as well as structured globular domains. The majority of proteins in eukaryotic proteomes contain both IDRs and structured regions. In this Review, we use IDP as a generic term to denote a protein that contains extensive disorder that is important for function. A discussion of the classification of IDPs and IDRs was recently published 4 . IDPs frequently interact with, or function as hubs in, protein-interaction networks 5, 6 . They have a central role in the regulation of signalling pathways and crucial cell ular processes, including the regulation of transcription, translation and the cell cycle 1, [7] [8] [9] . The abundance of IDPs in the cell is tightly regulated to ensure precise signalling in time and space, and mutations in IDPs or changes in their cellu lar abundance are associated with disease [10] [11] [12] . In addition to their regulatory functions, IDPs play a central part in the ordered assembly of macromolecular machines such as the ribosome, in the organization of chromatin, in the assembly and disassembly of microfilaments and microtubules, in transport through the nuclear pore, in the binding and transport of small molecules, in the functioning of protein and RNA chaperones, and in the separation of functional protein domains (as flexible 'entropic' linkers) [13] [14] [15] [16] . An exciting recent finding is that many proteins containing low-complexity or prion-like sequences can promote phase separation to form membrane-less organelles within the cytoplasm or nucleoplasm, thus contributing to their compartmentalization in a regulated manner 17, 18 . The broader roles of IDPs in biology have been discussed in many excellent recent reviews and will not be revisited here.
The physical characteristics of IDPs allow an exquisite level of control of cellular signalling processes. Their favourable characteristics include: the presence of small recognition elements that fold on partner binding; a degree of flexibility, which enables them to interact promiscuously with different targets on different occasions; accessible sites for post-translational modificatio n; e fficient utilization of conserved sequence motifs to mediate binding interactions; the ability to bind partners with high specificity but modest affinity, leading to CREB  MYB  MLL  BRCA1  p53  HTLV-1 TAX  JUN  FOXO3A   E1A  PCAF  MEF2  STAT1  ETS1  p53  C/EBP  HDAC1   p160  ACTR  HTLV-1 TAX  ETS2  STAT6  IRF3  p53 KID domain P rapid and spontaneous dissociation and termination of the signal 1, 3, 19 ; kinetic advantages in signalling 20 , as their extremely fast association rates allow signals to be rapidly turned on. In performing their signalling functions, IDPs bind transiently to multiple interaction partners in dynamic regulatory networks 21 that respond precisely and quantitatively to cellular signals and have the potential for complex information processing. The molecular interactions are transient and dynamic: IDPs exchange binding partners and compete for binding to central hub proteins, which are often present in limiting amounts. These interactions are fine-tuned by post-translational modifications that enable them to function as switches and rheostats 3, [22] [23] [24] [25] [26] . In this Review, we focus on the well-documented roles of IDPs in the regulation of intracellular signalling, in which the role of proteins with flexible structures and extensive dynamics is well understood (FIG. 1) . We discuss how intrinsic disorder functions to enhance and propagate signalling. The multiplicity of protein-interaction motifs in IDPs and their capacity for regulation through posttranslational modification bring important advantages to the signalling process. For example, the same amino acid sequence can be used in different contexts and in response to different signals to turn different signalling pathways on or off and cause different cellular responses. These attributes also contribute to pathway crosstalk and to the operatio n of positive-and negative-feedback circuits.
Characterization of protein disorder
Several web servers have been developed for the prediction of protein disorder on the basis of sequence analysis. A database has been established that contains consensus disorder predictions for all proteins coded by the human genome 27 
. Major advances have been made in the development of experimental and computational tools to characterize disorder and to generate structural ensembles of disordered proteins. Modelling of ensembles [28] [29] [30] is based primarily on nuclear magnetic resonance (NMR) and small-angle X-ray scattering (SAXS) data, and the public website Protein Ensemble Database (pE-DB) has been established for the deposit of conformational ensembles 31 . Structures of IDRs in their bound states can be obtained by X-ray crystallography, if they are well ordered, or by NMR, which has the additional advantage of providing insights into dynamic interactions between IDPs and their targets. Single-molecule fluorescence energy transfer (smFRET) and computer simulations based on polymer physics are playing an increasingly important part in the characterization of IDPs [32] [33] [34] .
IDPs provide multiple interaction motifs Intracellular signalling is accomplished by dynamic networks of interacting proteins; intrinsic disorder has a prominent role in mediating these interactions. The disordered regions of signalling and regulatory proteins frequently contain multiple conserved sequence motifs that interact with nucleic acids or other proteins 3, 35 . Amphipathic sequence motifs and short linear motifs that mediate binding can be readily identified by bioinformatic analyses 36, 37 . ) binds to a structured, membranebound cell surface receptor, a G protein-coupled receptor (GPCR), causing the translocation of the α-subunit of the coupled G protein to the membrane-bound adenylyl cyclase, with concomitant formation of GTP from GDP. Cyclic AMP (cAMP) is generated and activates protein kinase A (PKA) by releasing the regulatory subunit (R), which has two downstream effects. First, it initiates the phosphorylation cascade that results in the phosphorylation of glycogen and the mobilization of stored glucose. Second, activated PKA is translocated to the nucleus, where it phosphorylates the transcription factor cAMP-responsive element-binding protein (CREB), an intrinsically disordered protein (IDP). CREB is constitutively bound to the CRE DNA sequence through dimerization of the carboxy-terminal basic Leu zipper (bzip) domain. Phosphorylation of the kinaseinducible (KID) domain causes this domain to bind to and fold into a helical structure on the KIX domain of the transcriptional co-activator CREB-binding protein (CBP), recruiting it to the promoter and promoting the transcription of downstream signalresponse genes (reviewed in REF. 145 ). In this case, IDPs function both in the original reception of the signal and in the promotion of gene transcription in response to the signal. b | Domain organization of a typical IDP, CBP (with globular domains represented as spheres), showing a subset of the IDPs that bind to each of the four main interaction domains: the folded domains transcriptional adaptor zinc-finger 1 (TAZ1), KIX and TAZ2, and the disordered (probably molten globular) nuclear co-activator-binding domain (NCBD). ACTR, co-activator for thyroid hormone and retinoid receptors; BRCA1, protein product of breast cancer gene 1; C/EBP, CCAAT/enhancer-binding protein; E1A, protein product of adenovirus early region 1A; FOXO3A, forkhead box O3A protein; HDAC1, histone deacetylase 1; HIF1α , hypoxia-inducible factor 1α; HTLV-1 TAX, human T-lymphotrophic virus-1 TAX protein; IRF3, interferon regulatory factor 3 protein; MEF2, myocyte-specific enhancer factor 2; MLL, mixed-lineage leukaemia protein; NF-κB, nuclear factor-κB; PCAF, p300/CBP-associated factor (also known as KAT2B); PIT1, pituitary-specific positive transcription factor 1 (also known as POU1F1); STAT, signal transducer and activator of transcription.
Association rates
The speeds with which complexes are created from their component parts. The speed of the reverse process, detachment of the components, is known as the dissociation rate. The binding affinity is determined by the relative magnitude of the association and dissociation rates; for example, a fast association rate ('on-rate') and a slow dissociation rate ('off-rate') is characteristic of a high-affinity complex.
Conformational ensembles
Structural descriptions of proteins that do not have a single, well-ordered three-dimensional structure. Conformational ensembles contain a multitude of different interconverting structures, which, when averaged, are consistent with observed parameters, such as nuclear magnetic resonance (NMR) spectra or small-angle X-ray scattering data.
Recent estimates suggest that the human proteome may contain more than 100,000 short linear binding motifs located within IDRs 38 . An important feature of the recognition elements in many IDPs is that they exhibit structural polymorphism, adopting different structures on different targets 3 . An extreme example is the nuclear coactivator-binding domain (NCBD) of the CREB-binding protein (CBP; also known as CREBBP), which folds into two quite different structures when bound to the activation domain of p160 nuclear receptor co-activators 39, 40 or to interferon regulatory factor 3 (IRF3) 41 .
Coupled folding and binding. The mechanism by which disordered interaction motifs associate with and fold upon binding to their targets, a process known as coupled folding and binding 35, 42 , has recently received much attention through numerous experimental and theoretical studies that are beyond the scope of this Review. The presence of pre-formed secondary structural elements in the conformational ensemble of the IDP has been predicted to favour the binding process 43 , but experimental evidence so far does not uniformly support this hypothesis.
Binding of the phosphorylated kinase-inducible domain (pKID) of cyclic AMP (cAMP)-responsive element-binding protein (CREB) to the KIX interaction domain of CBP occurs through an induced folding mechanism, in which pKID binds in a disordered state and folds on the surface of KIX 44 . Subsequent studies of the kinetics of binding of five different IDPs to KIX [45] [46] [47] and of the disordered protein PUMA (also known as BBC3) to myeloid leukaemia cell differentiation 1 (MCL1) 48 show that, for each of these IDPs, folding is induced by binding and that having a pre-formed helical structure does not influence the rate of association with their target proteins. Association is remarkably fast and is diffusion-limited, which is advantageous for a rapid signalling response in the cell. Initial association of the disordered activation domain of the p160 co-activator ACTR (co-activator for thyroid hormone and retinoid receptors; also known as NCOA3) with the disordered, molten globular NCBD domain of CBP is also extremely rapid but is followed by slow conformational transitions, which are presumably associated with the folding process 49 . However, in contrast to the results described above, an increase in the population of a pre-formed ACTR helix led to a modest increase in the association rate 50 . The effect that stabilizing a pre-formed helical structure has on partner binding affinity has been investigated through amino acid substitution to insert helix-favouring amino acids, as well as by covalent modification to 'staple' the peptide into a helical conformation 51 . Stabilization of a pre-formed helix in some disordered peptides seems to have a rather small effect in enhancing the binding affinity for the target proteins and it can even destabilize the complex 52, 53 . Two recent papers suggest that the population of helica l structures in the unbound state, which is controlled by the IDP sequence, is an important determinant of biological function. The population of pre-formed helical structures in a linker region of the p27 cyclindependent kinase (CDK) inhibitor directly mediates its ability to regulate the cell cycle, with variants that reduce the intrinsic linker helicity being deficient in promoting cell cycle arrest 54 . The population of pre-formed helical structures in the intrinsically disordered amino-terminal transactivation domain of the p53 (also known as TP53) tumour suppressor has been implicated as a determinant of MDM2-binding affinity 55 . In the absence of a binding partner, wild-type p53 has a very low helical content in the MDM2-binding motif. The population of helices is tuned by conserved Pro residues; substitution of a flanking Pro residue (Pro27) with Ala greatly increases the residual helicity and enhances the affinity for binding MDM2. However, this enhanced MDM2-binding affinity upsets the delicate balance of protein-protein interactions in p53 signalling pathways and is deleterious to p53 function. Substitution of mutant p53 for endogenous p53 in cells alters the dynamics of p53 accumulation, impairs target gene expression and culminates in failure to induce cell cycle arrest after DNA damage 55 . Overall, much remains to be understood about the functional importance of pre-formed structures, which seems to depend strongly on the particular system under study. Nevertheless, for p27 and p53 at least, it is already clear that the intrinsic helical propensity is finely tuned by the protein sequence and is an important determinant of signalling fidelity 54, 55 .
Disordered regions can form 'fuzzy' complexes. Not all
IDPs undergo folding transitions in performing their biological functions; some disordered regions seem to function as flexible unstructured linkers between globular or disordered interaction domains 3, 56, 57 , and some IDPs remain disordered even after binding to their targets 58, 59 , forming 'fuzzy' complexes 60 . IDPs often form dynamically heterogeneous complexes with their targets, interacting through well-ordered and fully structured 'static' interfaces plus additional disordered dynamic (or fuzzy) sites on distinct, non-overlapping surfaces of the target protein 61, 62 . Functionally, such dynamic binding inter actions can enhance target-binding affinity, mediate pathway crosstalk through the formation of ternary complexes with other binding partners, and modulate allosteri c interactions 63 .
Box 1 | Prediction of intrinsic disorder from sequence
The likelihood that an amino acid sequence will be disordered rather than part of a well-structured three-dimensional fold can be evaluated both experimentally and using bioinformatics. The most convenient method for identifying disordered regions in amino acid sequences is to use the powerful bioinformatics prediction tools that have been developed over the past 15 years or so. Programs such as The DisProt Predictor of Protein Disorder (DisProt) 134 , Prediction of Intrinsically Unstructured Proteins (IUPred) 135, 136 (and the associated program ANCHOR 137, 138 , a predictor of binding sites), Predictor Of Naturally Disordered Regions (PONDR) 139 , PrDOS 140 and ESpritz
141
, analyse local sequence composition, with relatively higher proportions of small hydrophilic amino acids indicating a sequence with greater probability of disorder. These programs are available through the DisProt database 146 . Hidden Markov models have also been applied to identify disordered and structured domains 142 . An extremely convenient means of accessing disorder predictions is through the Database of Disordered Protein
2 is an interactive website that presents a compilation of disorder predictions for all sequences in the human proteome, as predictions made using each of the above algorithms and also as an overall consensus.
Binding free energy
The difference in free energy (ΔG) between the free and bound states of a complex. If the complex is stable, the binding free energy is negative.
IDPs as signalling hubs
Because IDPs and IDRs of large multifunctional proteins frequently contain multiple interaction motifs that mediate binding to diverse targets, they commonly function as central hubs in signalling networks 5, 6 . The ability to bind their targets through multiple sites confers on IDPs specific properties that facilitate the dynamic assembly of ternary and higher-order complexes and the integration of diverse signalling pathways. The existence of multiple binding sites also enables allosteric responses in biological signalling, and the energetics of the binding process is exquisitely tuned by the large variations in entropy between free and bound states 64 .
Non-homogeneous distribution of binding free energy.
Knowledge of how the binding free energy is distributed over the IDP-target interface is of great importance for understanding the functional interactions of IDPs. The interactions between an IDP that contains multiple binding motifs and its target will only rarely be energetically uniform. Binding will frequently be dominated by residues in local hotspots that contribute most of the binding free energy, whereas other regions may interact only weakly and contribute to a lesser extent, but still significantly, to the overall binding affinity. An example of this can be seen in the interaction between the transcriptional activation domain of RELA and the transcriptional-adapto r zinc-finger 1 (TAZ1) domain of CBP 65 (FIG. 2a) . Ala mutagenesis shows that binding is dominated by three amphipathic motifs in RELA that dock within hydrophobic grooves in the surface of the TAZ1 domain. Additional contacts are made by a transient amphipathic helix in the amino-terminal region of the RELA activation domain, but these contribute little to the overall binding energy. NMR experiments show that the interactions are dynamic and that this region of the RELA sequence fluctuates between bound and free states, and between helical and extended conformations 65 . Nevertheless, the transient binding sites contribute non-zero binding free energy, as truncation of these regions leads to a measurable decrease in affinity 65 .
Pathway crosstalk. The presence of a weak dynamic interface has advantages in a signalling network: when IDPs containing multiple interaction motifs bind to their targets through weak dynamic interfaces in addition to well-structured static interfaces, conformational fluctuations transiently expose the dynamic interaction motif, facilitating post-translational modifications and/ or interactions with other target proteins. For example, the p120 catenin (also known as CTNND1) regulates the stability of cell-cell adhesion by binding the intrinsically disordered cytoplasmic tail of cadherin through both static and dynamic interfaces 62 (FIG. 2b) . The core region of the cadherin tail imparts specificity to the interaction and binds strongly to p120 through a well-structured static interface. By contrast, an N-terminal flanking region interacts only weakly and dynamically with p120, fluctuating between free and bound states. This dynamic binding site contributes little to binding affinity but has an important function in determining the cellular fate of cadherin: by masking a critical Leu-Leu motif, this region hinders internalization by clathrin-mediated endocytosis.
A similar situation is observed in the intrinsically disordered adenovirus oncoprotein early region 1A (E1A) 66 , which illustrates how promiscuous interactions through multiple binding motifs can modulate signalling outcomes. E1A uses its N-terminal region, conserved region 1 (CR1) and CR2 to recruit key cellular regulatory proteins and subvert cellular signalling pathways, force entry into S phase of the cell cycle and activate transcription of viral genes 67 FIG. 2c) . By incorporating multi ple binding motifs within an IDR, E1A functions as a hub that can bind promiscuously to numerous cell ular proteins and organize them combinatorially into higherorder complexes that efficiently disrupt regulatory networks and reprogramme gene expression. Indeed, the N-terminal region and CR1 function synergistically to activate CBP and/or its paralogue p300 (also known as EP300)-mediated transcription of viral genes from the adenovirus E2 promoter 68 and to repress transcription of a subset of cellular genes involved in proliferation and differentiation 69 .
Weak binding sites function in synergy. Even in the absence of a localized high-affinity interaction motif, IDRs can bind tightly to their targets through the synergistic action of multiple weak binding sites. The APC/ C (anaphase-promoting complex; also known as the cyclosome) controls cell division by promoting ubiquitin-mediated degradation of cyclins and other proteins involved in the regulation of the cell cycle. The 1.5-MDa APC/C and CDC20 homologue 1 (APC/C CDH1 ) complex is inhibited during interphase by a 143-residue region of the protein early mitotic inhibitor 1 (EMI1; also known as FBXO5), which contains a zinc-binding domain embedded in an IDR 70 . The IDR contains multiple interaction motifs, which mediate interactions with multiple sites on APC/C CDH1 . The individual binding sites in EMI1 interact only weakly with the APC/C CDH1 but function synergistically to form a high-affinity complex through multisite binding. Because binding at individual sites is weak, fluctuations between free and bound states make EMI1 accessible to kinases that can regulate the APC/C CDH1 interaction through phosphorylation. By using intrinsic disorder, EMI1 is able to bind dynamically through multiple recognition motifs to regulate a large molecular machine 100 times its size.
Allostery in IDP-mediated signalling. Allostery plays a central part in the regulation of cellular signalling networks 71 . Because of their conformational plasticity, their ability to bind multiple targets with high specificity and low affinity, and their propensity for post-translational modification, IDPs display complex allosteric behaviour that can fine-tune their regulatory interactions 72 . Indeed, theoretical considerations suggest that allosteric coupling is optimal when one or both of the coupled binding sites is intrinsically disordered 73 . Allosteric regulation by IDPs was first observed experimentally for the phd-doc toxin-antitoxin operon from bacteriophage P1 (REF. 74 ). . The amino-terminal helix (green) is only transiently populated, and it is dynamically disordered on a nanosecond timescale yet contributes to binding affinity. The figure was generated from coordinates 2LWW and data in REF. 65 . b | Schematic illustration of pathway crosstalk mediated by differential binding of an intrinsically disordered protein (IDP). The disordered cytoplasmic tail of epithelial cadherin (E-cadherin) binds to the armadillo-repeat region of the p120 catenin through interaction of conserved sequence motifs containing phosphorylated Tyr (Y) and Glycine (G) residues at a high-affinity 'static' binding site, while the Leu-Leu (L-L) motif binds at the dynamic site, effectively chaperoning this region. The adaptor protein (AP) recognizes the exposed L-L motif, leading to clathrin-mediated endocytosis of E-cadherin. c | Interactions between the adenovirus oncoprotein early region 1A (E1A) and cellular proteins. The intrinsically disordered N-terminal (N) region of E1A binds numerous cellular proteins to disrupt cellular regulation. These interactions function in the repression of cellular genes, in chromatin remodelling and transcriptional activation, and in the cytoplasm. Interactions with RB are essential for dysregulation of the cell cycle, whereas binding to CBP or p300 (green) disrupts cellular transcriptional programmes. d | Schematic summary of the allosteric modulation of the E1A signalling network through complex formation with CBP and RB. Signalling pathways are modulated allosterically by interactions with various binding partners, as represented by a central phase diagram of the hub, with four states of E1A: free, E1A-RB, E1A-CBP/p300 and the ternary complex of all three. Circles outside the hub show additional protein partner interactions that influence regulatory pathways within the cell. CR, conserved region; PKA, protein kinase A; PCAF, p300/CBP-associated factor (also known as KAT2B); RACK1, receptor for activated kinase C 1 (also known as GNB2L1); TBP, TATA-box-binding protein; TR, thyroid hormone receptor; TRRAP, transformation/ transcription domain-associated protein. of the glucocorticoid receptor 75 and in the adenovirus E1A oncoprotein 63 . Interactions between E1A and the cellu lar proteins CBP and RB can display either positive or negative allostery, depending on the available E1A binding sites 63 . Modulation of allosteric interactions will probably emerge as a common mechanism by which the signalling functions of intrinsically disordered hub proteins are regulated and by which the ultimate outcome of signalling is determined (FIG. 2d) .
Allosteric effects associated with binding to IDRs could potentially be exploited in a new strategy for drug develop ment. It has recently been shown that the small molecule inhibitor MSI-1436 binds to the c arboxytermina l disordered region of the protein Tyr phosphatase PTP1B (also known as PTPN1) and, through an allosteric effect, locks the enzyme in an inactive state 76 . By inhibiting PTP1B, MSI-1436 inhibits HER2 (also known as ERBB2) signalling and limits tumour growth, making it a viable therapeutic candidate for the treatmen t of HER2-positive breast cancer.
Post-translational modifications
The enhanced flexibility and conformational plasticity of the disordered regions of proteins renders them readily accessible for post-translational modification, often resulting in dense clusters of modifications 77 . It has recently been estimated that, when post-translational modifications are taken into account, there may be as many as one million peptide-interaction motifs within IDRs of the human proteome 38 . This enormous number underscores the central role that IDPs have in cellular signalling and regulation, and sheds light on their remarkable functional diversity.
Modifications of an IDP by different kinases, acetylases, methylases or other modifying enzymes can result in different signalling outputs, adding great complexity to signalling pathways. Phosphorylation sites are located predominantly in IDRs 78 , and phosphorylation plays a major part in modulating the conformational ensemble and interactions of disordered signalling proteins. Signalling can be regulated by addition (or removal) of a single phosphoryl group, as for example in the activation of the cAMP-regulated transcription factor CREB through phosphorylation at Ser133 in the intrinsically disordered kinase-inducible activation domain 79, 80 (FIG. 3a) . However, intrinsically disordered signalling proteins frequently contain multiple phosphorylation sites that can be modified sequentially or combinatorially to exert exquisite control over the signalling output (FIG. 3b-d) . By changing the bulk electrostatics, multisite phosphorylation can generate protein rheostats or ultrasensitive protein switches that are triggered at a threshold level of phosphorylation.
Phosphorylation switches and threshold responses.
In yeast, multisite phosphorylation of the intrinsically disordered Cdk1 inhibitor Sic1 late in the G1 phase of the cell cycle acts as a switch that commits the cell to proceed to S phase 81 . Progressive phosphorylation of Sic1 by Cdk1 promotes degradation of Sic1 by enhancing binding to the Cdc4 subunit of the Skp1-Cullin 1-F-box (SCF) ubiquitin ligase. Sic1 contains nine sub-optimal phosphodegron motifs, which individually bind only weakly to Cdc4. High-affinity binding to Cdc4 occurs only after phosphorylation of any six of the phosphodegron sites. Progression from G1 phase is delayed until this phosphorylation threshold has been reached, after which Sic1
Box 2 | Motif mimicry and the role of intrinsically disordered proteins in viral infection
There are numerous examples of cellular signalling cascades that are subverted by viral proteins 132 . The proteins that viruses use to hijack cellular signalling networks are very often intrinsically disordered, and they frequently have higher affinities for their cellular targets than the natural sequences. For example, the adenovirus oncoprotein early region 1A (E1A) is disordered in solution and binds to the transcriptional adaptor zinc-finger 2 (TAZ2) domain of the cellular transcriptional co-activator CREB-binding protein (CBP) with a dissociation constant (K d ) of 3 nM ), allowing the viral protein to compete successfully for CBP 61 and block cellular transcription programmes. The subversion of cellular regulation by viral proteins does not consist solely of out-competing cellular proteins for binding to the scarce CBP and p300 co-activator molecules. Intrinsically disordered proteins, such as E1A, provide multiple binding sites that allow them to recruit cellular proteins into higher-order assemblies. Formation of an E1A-mediated ternary complex between the CBP or p300 TAZ2 domain and RB (see the figure) facilitates the disruption of the cell cycle by the virus: by bringing the CBP histone acetyl transferase (HAT domain) and the cell cycle regulatory protein RB into proximity, E1A promotes acetylation and degradation of RB, forcing S phase entry and uncontrolled proliferation 61 . By mimicking intrinsically disordered cellular proteins, viruses make very efficient use of their small genomes. becomes degraded in a switch-like, ultrasensitive, sigmoidal response 81 (FIG. 3b) . Activation of the switch is entirely dependent on intrinsic disorder in Sic1 and its complex with Cdc4 (REF. 82 ). Sic1 forms a highly disordered complex with Cdc4, in which individual phosphodegron motifs interact only weakly with Cdc4 and exchange dynamically between free and bound states. Unbound phosphate groups contribute to binding affinity through electrostatics, and the cumulative electrostatic interactions drive an ultrasensitive switch-like response when a threshol d level of phosphorylation is reached 24 .
Coincidence detectors. Sequentially ordered phosphorylation cascades can function as logical ' AND' operations in signalling networks 83, 84 , so that signalling occurs only when all sites are phosphorylated. Such a cascade functions to degrade the establishment of cohesion 1 (Eco1) protein and prevent excess chromatid adhesion after the S phase of the cell cycle in yeast 85 . Degradation requires sequential phosphorylation of Ser and Thr residues in an IDR of Eco1. Phosphorylation of Ser99 by Cdk1 acts as a priming event that allows stepwise phosphorylation at Ser98, by the cell cycle-regulated kinase Cdc7-Dbf4, and then at Thr94, by meiosis and centromere regulatory kinase 1 (Mck1). Precise spacing between the phosphoryl groups at Ser98 and Thr94 is required to create a binding site for the Cdc4 subunit of the SCF ubiquitin ligase 85 . This phosphorylation cascade functions as a coincidence detector (FIG. 3c) , integrating inputs from three distinct kinases and thus imparting exquisite control over the biological outcome, degradation of Eco1 and prevention of sister chromatid adhesion.
Molecular rheostats.
Transcriptional pathways regulated by the p53 tumour suppressor are activated by a cascade of post-translational modifications in the intrinsically disordered N-terminal transactivation and C-terminal regulatory domains of p53 (REF. 86 ). In unstressed cells, p53 levels are kept low by continual proteasomal degradation, which is mediated by the MDM2 ubiquitin ligase. Genotoxic stress initiates a phosphorylation and acetylation cascade that leads to stabilization and accumulation of p53, arrest of cell growth and apoptosis 87, 88 . The stability and transcriptional activity of p53 is tightly regulated through its interactions with MDM2 and the transcriptional co-activators CBP and p300 (REFS 89, 90) . Phosphorylation at Thr18, which requires prior phosphorylation at Ser15, decreases the affinity for binding the E3 ubiquitin ligase MDM2 and thereby helps to stabilize p53 against proteasomal degradation [90] [91] [92] . Activation of p53-regulated transcriptional programmes requires the recruitment of CBP or p300 and subsequent acetylation of the C-terminal regulatory domain of p53. Whereas interactions with MDM2 are primarily regulated by a Thr18 phosphorylation switch, binding of p53 to CBP or p300 is modulated by a phosphorylation rheostat, with successive phosphoryl ation events in the intrinsically disordered N-terminal transactivation domain enhancing the binding affinity in an additive manner 23 (FIG. 3d) .
This graded response to multisite phosphorylation progressively enhances the ability of p53 to recruit CBP or 79, 80 . b | In the Sic1-SCF (Skp1-Cullin 1-F-box) ubiquitin ligase system 81 , the response to phosphorylation at multiple sites takes the form of sigmoidal threshold response curves, with cooperativity increasing as an increasing number of sites (1-6) are phosphorylated. c | The interaction of establishment of cohesion 1 (Eco1) with the Cdc4 subunit of the SCF ubiquitin ligase 85 shows coincidence detection, in which a certain threshold level of phosphorylation must be achieved before response is initiated. d | Under conditions of genotoxic stress, the affinity of the p53 transactivation domain for CBP/p300 (REF. 23 ) increases with each successive phosphorylation event, relative to the affinities of other transcription factors (denoted TF1 and TF2). This is an example of a rheostat response. Cdk1, cyclin-dependent kinase 1; Mck1, meiosis and centromere regulatory kinase 1; Rbx1, RING box 1. p300 in competition with cellular transcription factors, gradually increasing the efficiency of the p53 response follow ing severe or prolonged cellular stress 23 .
Molecular clocks.
The fractional content of charged residues and their distribution in the sequence has a profound influence on the dimensions and degree of compaction of IDPs 33, 34, 93 . Changes in net charge and charge distribution resulting from multisite Ser and Thr phosphorylation can thus strongly influence the conformational propensities of an IDP through bulk electrostatic effects. An example of this is seen in the time-delayed regulation of the Neurospora spp. circadian clock by progressive phosphorylation of the protein frequency (FRQ) 94 . FRQ is predicted to be disordered over most of its length, with an asymmetric distribution of positive and negative charge. Over the course of a day, FRQ becomes progressively phosphorylated at as many as 113 sites 95, 96 . At low levels of phosphorylation, two isolated amphipathic motifs interact to form a closed state that recruits casein kinase 1a. Slowly progressing phosphorylation of up to 46 non-consensus sites in the disordered N-terminal domain of FRQ leads to a steady accumulation of negative charge, which destabilizes the closed state and triggers a transition to an open conformation. This timed change in conformation or compaction of FRQ exposes a PEST signal, which results in protein degradation to reset the circadian clock. FRQ functions as a 'molecular hourglass' (REF. 94 ), in which time is 'measured' by the number of phosphorylated residues and not by specific interactions mediated by individual phosphorylation sites. This clock mechanism is driven by the extensive intrinsic disorder in FRQ, which ensures that a large number of phosphorylation sites are accessible within a flexible polypeptide that can readily undergo changes in molecular compaction in response to changes in electrostatic charge.
Temporal regulation of the cell cycle is also achieved through multisite phosphorylation processes at clustered sites within IDRs 97 . Timing and coordination of the cell cycle is orchestrated by CDKs, which catalyse phosphoryl ation of numerous downstream targets. For example, multi site phosphorylation by the yeast cycli n-Cdk1-Cks1 complex is controlled by the distance between phosphoryl ation sites on the substrate protein, the distribution of Ser and Thr phospho-acceptors in these sites, and the efficiency of phosphorylation of individual motifs 98 . Thus, the output signal is determined in part by the sequence and spatial pattern of the multisite phosphoryl ation cluster embedded in an IDR.
Autoinhibitory sequences. The activities of many signalling proteins are negatively regulated in cis by autoinhibitory sequences 99 . A recent bioinformatic analysis has shown that the inhibitory modules of autoinhibited proteins are enriched in disorder and contain multiple phosphorylation sites and structural variability, which can function combinatorially to ensure tight control of activation 100 . For example, in the VAV1 guanine nucleotide exchange factor, the catalytic Dbl homology (DH) domain is inhibited in cis by a dynamic helical motif in the adjacent acidic domain 101, 102 (FIG. 4) . The ~50-residue long acidic domain, which is predicted to be intrinsically disordered in the free state, interacts with the neighbouring calponin homology (CH) and DH domains in the autoinhibited state to form localized helical elements separated by disordered regions. The CH and DH domains act cooperatively to bind the acidic domain, leading to tight inhibition and finely tuned mechanisms of activation. Dynamic fluctuations between the bound and free (d issociated) states of the acidic domain expose crucial Tyr residues to phosphorylation, resulting in a phosphoryl ation cascade that triggers dissociation and unfolding of the inhibitory helix and leads to activation of the DH domain 101, 102 . The dynamic and cooperative nature of the interactions between the intrinsically disordered inhibitory module and the core domains of VAV1 fine-tune its activity. Alternative splicing (see below) is also common in intrinsically disordered autoinhibitory domains, providing a mechanism for regulation of the activation process in a tissue-specific manner 100 .
Higher-order signalling assemblies Recent studies have shown that regulatory proteins frequently form higher-order assemblies -signalosomes -that amplify signals, reduce noise, promote threshold signalling responses and provide spatial and temporal control over signalling 103 . IDRs play an important part in the assembly of a subset of signalling complexes, through fully reversible protein-protein interactions that promote formation of reversible cellular assemblies 104 and through formation of ultra-stable amyloid scaffolds 105 . The RIP1 (also known as RIPK1) and RIP3 (also known as RIPK3) kinases assemble into a signalling complex that is required for programmed necrosis by formation of a heterodimeric amyloid fibril 105 . Fibril formation is mediated by short, amyloidogenic RHIM sequences embedded within IDRs of RIP1 and RIP3. It was suggested that the disordered RHIM sequences are hidden in the inactive state but become exposed for amyloid and necrosome formation on kinase activation 105 . The mechanism by which these ultra-stable amyloid fibrils are disassembled to terminate signalling is not yet understood.
In an exciting recent advance, it has been demonstrated that low-affinity, multivalent protein-protein interactions, often mediated by low-complexity and prion-like intrinsically disordered sequences, can promote liquidliquid demixing to form membrane-less cytoplasmic and nuclear granules 17, 18, 106, 107 . These granules behave like dynamic liquid droplets, rapidly exchanging component proteins and RNA with the cytoplasm or nucleoplasm. By sequestering regulatory proteins under conditions of high macromolecular concentration, IDP-mediated phase separation can have a profound influence on cellular signalling. For example, in response to cellular stress, mammalian target of rapamycin complex 1 (mTORC1), a kinase that controls cellular growth and metabolism, becomes sequestered in an inactive form in stress granules. Reactivation of mTORC1 requires stress granule dissolution, a process that is mediated by dual-specificity Tyr phosphorylation regulated kinase 3 (DYRK3) 108 . The intrinsically disordered N-terminal region of in active DYRK3 targets it to the stress granules and prevents their Nature Reviews | Molecular Cell Biology dissolution. Activation of DYRK3 promotes dissolution of the stress granules and, by direct phosphorylation of the mTORC1 inhibitor PRAS40 (also known as AKT1S1), and leads to the release of reactivated mTORC1 for signalling 108 (FIG. 5) . Given the abundance of multivalent lowcomplexity sequences and prion-like sequences rich in Gln and Asn in RNA-binding proteins and transcription factors 17, 109 , it seems likely that phase separation plays a quite general but poorly understood part in cellular signalling.
Alternative splicing and disorder More than 90% of human genes undergo alternative splicin g, which frequently leads to expression of distinct protein isoforms in different cell types and tissues 110 .
Tissue-specific splicing. Tissue-specific splicing, which results in protein isoforms that make distinct inter actions in different tissues, has central roles in development and cellular differentiation 111, 112 . Protein segments encoded by tissue-specific exons are enriched in disorder, whereas constitutive exons more often encode folded protein domains 111, 112 . These IDRs are rich in interaction motifs and sites for post-translational modification, and they tend to occupy central positions in cellular interaction networks. Tissue-specific splicing thus modulates the binding properties of critical regulatory proteins and differentially adjusts the signalling networks in different cell types or tissues.
Disorder in the splicing machinery. IDPs have a key role in both constitutive pre-mRNA splicing and alternative splicing, processes that are catalysed by the spliceosome, a large and highly dynamic ribonucleoprotein machine. The protein components of the spliceosome are highly enriched in intrinsic disorder 113 , as are the alternatively spliced segments of the protein substrates 114 . Proteins involved in spliceosome assembly and mRNA recognition, such as the retention and splicing complex RES, have a strong propensity for disorder, whereas proteins like the small nuclear ribonucleoprotein particle proteins that comprise the catalytic core of the spliceosome tend to be highly ordered 113 . Spliceosome assembly and conformational rearrangement is regulated by reversible post-translational modifications in disordered regions. Splicing of pre-mRNA is regulated through a dynamic cycle of multisite phosphorylation and dephosphorylation of Ser residues in intrinsically disordered Arg-and Ser-rich regions (termed RS or SR domains) of splicing factors 115, 116 . Recent NMR studies show that unphosphorylated RS domains are fully disordered and highly dynamic and are susceptible to efficient phosphorylation by a number of kinases 117 . Multisite phosphorylation acts as a dynamic switch that favours a more rigid arch-like structure, with well-defined orientations of the Arg and Ser side chains in the RS repeats. The extent of ordering of the RS domain depends on the number of RS repeats and the number of phosphoryl groups. It has been suggested that the interactions of the RS domain with RNA and with other proteins are modulated through entropic changes and the increased charge associated with progressive phosphorylation 117 . Indeed, recent evidence suggests a role for RS domains in regulating the compartmentalization of splicing factors within the nucleus. RS domaincontaining proteins first localize to the nucleolus in a hypophosphorylated state, and then they are distributed to nuclear speckles in response to phosphorylation by CDC-like kinase 1 (CLK1)-and CLK2-family kinases 118 .
RNA polymerase and splicing. The C-terminal domain (CTD) of RNA polymerase II plays a central part in coupling transcription to pre-mRNA splicing and alternative splicing (reviewed in REF. 119 ). This domain contains 52 YSPTSPS heptad repeats in vertebrates, is predicted to be intrinsically disordered and is subject to extensive post-translational modification 120 . The CTD functions as a long and flexible tether, regulated by phosphorylation, acetylation and methylation, that recruits splicing factors and other proteins to the polymerase elongation complex 121 . The intrinsically disordered CTD may also promote efficient co-transcriptional splicing across introns of highly variable length by tethering the downstream and upstream exons in close proximity 122 .
Future perspectives
In the past decade, concepts of protein disorder have penetrated deeply into the fields of molecular and cell biology. It is now recognized that IDRs of proteins are mechanistically involved in a staggering range of cellular processes. Recent technical advances give great promise of rich future perspectives in the detection and character ization of IDPs. One of the most exciting developments has been the beginnings of biophysical studies of IDPs within the cell. By introducing iso topically or fluorescently labelled proteins into the cell, NMR and fluorescen ce method s can be used to investigate the structural propensities and interactions of IDPs in their natural cellular environ ments. Although such studies are currently in their infancy, they offer enormous promise for probing the dynamic interactions of IDPs within the cell. A disordered acidic domain inhibits the VAV1 guanine nucleotide exchange factor by interacting in cis with the catalytic Dbl homology (DH) and calponin homology (CH) domains, forming localized helical elements that incorporate Tyr residues. The acidic domain undergoes dynamic fluctuations, exposing the Tyr residues to phosphorylation, which results in dissociation of the bound inhibitory domain and activation of VAV1 (REFS 101, 102 124, 125 . Many questions remain to be answered about the structure, interactions and localization of IDPs within the environment of the cell. Are signalling IDPs always fully sequestered by target proteins or are there significant populations of unbound and dis ordered proteins inside the cell? How do post-translationa l modifications alter the conformational ensemble, the subcellular localization and interaction networks of IDPs? Are IDPs distributed homogeneously through the cytoplasm or nucleoplasm or are they concentrated in subcellular organelles and puncta? Can we characterize the dynamic interactions between IDPs and their target proteins within living cells?
Another major challenge will be the structural characterization of full-length IDPs containing both folded and disordered domains. Until quite recently, experimental approaches have, by necessity, been reductionist: large multi-domain proteins have been analysed as fragments, and their interactions with physiological partners examined in vitro by atomic-scale biophysical approaches, such as X-ray crystallography and NMR. Very few full-length IDPs have been characterized structurally, a notable exception being the p53 tetramer 126 . However, large modular IDPs do not function as isolated domains; instead, their component regions, both ordered and disordered, act synergistically in performing their cellular functions. To fully understand these complex systems, it will be important to take a more holistic approach, characterizing the structural ensembles, dynamics and interactions of the full-length proteins, or at least of large multi-domain fragments. The challenges should not be underestimated. Large proteins with both structured and disordered domains are extremely difficult to prepare intact, even from eukaryotic expression systems, and they frequently degrade to form truncated fragments during purification, probably because of the vulnerability of their disordered regions to protease. Such problems even arise during transient expression in mammalian cells. New approaches for expression, purification and biophysical analysis will be required. The rewards will be great, offering new insights into the mechanism by which structured domains, disordered regions, interaction motifs and post-translational modifications function synergistically to control cellular signalling networks.
The discovery that protein phase separation leads to formation of membrane-less compartments that have important functional roles in the cell has also opened up an important new field of study. Many questions remain to be addressed, including what roles IDPs and IDRs have in the assembly and disassembly of these organelles, and how they function to localize signalling proteins and thereby influence signalling pathways. Can we identify sequence motifs or identify prion-like domains that direct the assembly of phase separated states, and can this knowledge be used to predict the subcellular localization and potential function of IDPs?
Finally, there is growing interest in IDPs as potential targets for drug design. IDPs play a central part in key cellular signalling pathways and are frequently associated with disease 127 . They usually bind, often with modest affinity, to concave grooves in the surface of their targets through predominantly hydrophobic interactions 128 , making them very attractive therapeutic targets. This has led to recent efforts to synthesize conformationally constrained molecules that mimic the bound conformation of IDRs as a new and rational approach to design potent inhibitors of protein-protein interactions in vivo 129, 130 . It may even prove possible to design drugs targeted against the IDP itself, rather than its globular target, and success in this approach has recently been reported 76, 131 . We have much to learn from viruses, which frequently mimic cellular IDR motifs to subvert signalling networks and hijack the cellular regulatory machinery 132, 133 . Despite the promise of exploiting intrinsic disorder therapeutically, critical issues remain to be answered, such as whether it is better to target the IDPs themselves or to direct design efforts towards the grooves and pockets into which IDRs bind. Either way, targeting intrinsic disorder holds promise for a new era in drug discovery. Stress granules, which contain RNA and protein in a membrane-less condensed particle, form and coalesce in response to cellular stress, sequestering proteins, including dual-specificity Tyr phosphorylation regulated kinase 3 (DYRK3) and mammalian target of rapamycin complex 1 (mTORC1), the cellular factor that activates translation 108 . Translational silencing is mediated by DYRK3 under stress conditions through stabilization of stress granules by the interaction of the disordered amino-terminal tail, thus prolonging the sequestration of mTORC1. When cellular stress is relieved, DYRK3 and mTORC1 are released from the stress granules. Active DYRK3 acts as a kinase to phosphorylate PRAS40, relieving its inhibition of mTORC1 and allowing the resumption of protein synthesis. Reprinted from Cell, 152, Wippich, F. et al., Dual specificity kinase DYRK3 couples stress granule condensation/dissolution to mTORC1 signaling., 791-805, © (2013), with permission from Elsevier.
